Singapore markets closed
Straits Times Index
3,212.64 -6.36 (-0.20%) Nikkei
27,385.25 -34.36 (-0.13%) Hang Seng
19,915.68 -133.96 (-0.67%) FTSE 100
7,380.51 -119.09 (-1.59%) Bitcoin USD
27,932.88 -703.72 (-2.46%) CMC Crypto 200
607.46 -10.93 (-1.77%)
NeuroSense Therapeutics Ltd. (NRSN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:36AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 21.44M |
| Enterprise value | 13.17M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 2.73 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.22 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -60.66% |
| S&P500 52-week change 3 | -13.08% |
| 52-week high 3 | 5.2000 |
| 52-week low 3 | 1.0750 |
| 50-day moving average 3 | 1.6986 |
| 200-day moving average 3 | 1.7792 |
Share statistics
| Avg vol (3-month) 3 | 1.5M |
| Avg vol (10-day) 3 | 46.92k |
| Shares outstanding 5 | 11.78M |
| Implied shares outstanding 6 | N/A |
| Float 8 | N/A |
| % held by insiders 1 | 45.19% |
| % held by institutions 1 | 0.30% |
| Shares short (27 Feb 2023) 4 | 211.79k |
| Short ratio (27 Feb 2023) 4 | 1.76 |
| Short % of float (27 Feb 2023) 4 | 3.68% |
| Short % of shares outstanding (27 Feb 2023) 4 | 1.80% |
| Shares short (prior month 30 Jan 2023) 4 | 217.94k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Dec 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | N/A |
| Diluted EPS (ttm) | -0.7400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 0.68 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2023 Yahoo. All rights reserved.
